Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Dara Holder"'
Autor:
Charles G. Drake, Cory Abate-Shen, Guarionex Joel DeCastro, Max M. Kates, Renu K. Virk, Christopher B. Anderson, Bridget James, Wilson Sui, Dara Holder, Jamie S. Pak, Shing M. Lee, James M. McKiernan
Publikováno v:
The Journal of urology. 204(2)
For patients with bacillus Calmette-Guérin unresponsive or recurrent/relapsing nonmuscle invasive bladder cancer, multi-agent intravesical trials have been limited. In this study we investigate the safety of intravesical cabazitaxel, gemcitabine and
Autor:
Bridget Buckley-Matura, Charles G. Drake, Max Kates, Dara Holder, G. Joel DeCastro, Renu K. Virk, Jamie Pak, Christopher Anderson, Wilson Sui, Cory Abate-Shen, Shing M. Lee, James M. McKiernan
Publikováno v:
Journal of Urology. 201
Autor:
Max Kates, Rashed Ghandour, Arindam RoyChoudhury, Dara Holder, Jennifer Ahn, Mitchell C. Benson, James M. McKiernan, Gina M. Badalato, LaMont J. Barlow, G. Joel DeCastro
Publikováno v:
Journal of Urology. 192:1633-1638
Response rates to current second line intravesical therapies for recurrent nonmuscle invasive bladder cancer range between 10% and 30%. Nanoparticle albumin bound (nab-)paclitaxel has increased solubility and lower toxicity compared to other taxanes.
Autor:
Christopher Anderson, Shing Lee, Wilson Sui, Guarionex Joel DeCastro, Jamie Pak, Dara Holder, Cory Abate-Shen, James M. McKiernan
Publikováno v:
Journal of Urology. 197
Autor:
Ifeanyi Onyeji, Jennifer Ahn, Danny Lascano, Guarionex Joel DeCastro, James M. McKiernan, Cory Abate-Shen, Arindham RoyChoudhury, Dara Holder
Publikováno v:
The Lens
Autor:
Dara Holder, Jamie S. Pak, Guarionex Joel DeCastro, Christopher B. Anderson, James M. McKiernan, Wilson Sui, Shing Mirn Lee, Corinne T. Abate-Shen
Publikováno v:
Journal of Clinical Oncology. 35:313-313
313 Background: Salvage intravesical chemotherapy has shown benefit in patients with high-risk non-muscle invasive bladder cancer who fail first line therapy. Our preclinical murine intravesical trial showed a combination therapy was superior to sing
Publikováno v:
The Canadian journal of urology. 21(1)
We evaluated whether the extent of lymphadenectomy at the time of radical cystectomy for non-muscle invasive bladder cancer (NMIBC) impacts recurrence free survival.We conducted an IRB approved retrospective analysis of patients with clinical NMIBC w
Autor:
James, Lin, Michael, Whalen, Dara, Holder, Gregory, Hruby, G Joel, Decastro, James, McKiernan
Publikováno v:
The Canadian journal of urology. 20(2)
We examined the effects of neoadjuvant chemotherapy (NC) in the treatment of muscle invasive urothelial carcinoma of the bladder in those with mixed histology (MH) versus those with pure urothelial carcinoma (UC).Between 2000-2012, 195 patients were
Autor:
Mitchell C. Benson, James M. McKiernan, Arindam RoyChoudhury, Mark Mann, Gina M. Badalato, Dara Holder, Crystal Castaneda, LaMont J. Barlow, Jennifer Ahn
Publikováno v:
Journal of Urology. 189
Autor:
Ifeanyi Onyeji, Guarionex Joel DeCastro, Arindam RoyChoudhury, Dara Holder, Sam S. Chang, Danny Lascano, James M. McKiernan, Jennifer Ahn, Cory Abate-Shen, Neil Desai
Publikováno v:
Journal of Clinical Oncology. 34:e16008-e16008
e16008Background: Up to 40% of patients treated with intravesical agents for non-muscle invasive bladder cancer (NMIBC) will recur. Our lab has previously demonstrated the feasibility of mTOR inhib...